Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model

被引：0
|
作者：
Hanna, Bola [1 ]
McClanahan, Fabienne [1 ,2 ]
Clear, Andrew James [3 ]
Miller, Shaun [2 ]
Lichter, Peter [1 ]
Seiffert, Martina [1 ]
Gribben, John G. [3 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Barts Canc Inst, London, England
[3] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Age and Sex Differences in the Eμ-TCL1 Adoptive Transfer Mouse Model of CLL
    Sharpe, Chia
    Perry, Elizabeth
    Hertlein, Erin
    Muthusamy, Natarajan
    Byrd, John C.
    BLOOD, 2022, 140 : 12367 - 12368
  • [2] Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome
    Lanzolla, Giulia
    Coppelli, Alberto
    Cosottini, Mirco
    Del Prato, Stefano
    Marcocci, Claudio
    Lupi, Isabella
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (02): : 496 - 503
  • [3] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
    Naidoo, J.
    Page, D. B.
    Li, B. T.
    Connell, L. C.
    Schindler, K.
    Lacouture, M. E.
    Postow, M. A.
    Wolchok, J. D.
    ANNALS OF ONCOLOGY, 2015, 26 (12) : 2375 - 2391
  • [4] PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
    McClanahan, Fabienne
    Hanna, Bola
    Miller, Shaun
    Clear, Andrew James
    Lichter, Peter
    Gribben, John G.
    Seiffert, Martina
    BLOOD, 2015, 126 (02) : 203 - 211
  • [5] Increased susceptibility to Streptococcus pneumoniae pulmonary infection in the Eμ-TCL1 adoptive transfer mouse model of CLL
    Colado, Ana
    Bernatowiez, Juliana
    Cassarino, Chiara
    Martinez, Valeria Sarapura
    Bertini, Martin
    Bezares, Fernando R.
    Vermeulen, Monica
    Gamberale, Romina
    Giordano, Mirta
    Borge, Mercedes
    LEUKEMIA & LYMPHOMA, 2023, 64 : S182 - S183
  • [6] ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma
    Henry, Kelly E.
    Mack, Kyeara N.
    Nagle, Veronica L.
    Cornejo, Mike
    Michel, Adam O.
    Fox, Ian L.
    Davydova, Maria
    Dilling, Thomas R.
    Pillarsetty, Nagavarakishore
    Lewis, Jason S.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 2026 - 2034
  • [7] Associations of peripheral biomarkers to outcomes to anti-PD-L1 immune checkpoint blockade in metastatic urothelial cancer
    Yuen, Kobe C.
    Gupta, Vinita
    Li, Congfen
    Rishipathak, Deepali
    Kadel, Edward E.
    Chen, Ying-Jiun J.
    Goldstein, Leonard D.
    Modrusan, Zora
    Mariathasan, Sanjeev
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Molecular engineering of anti-PD-L1 peptide and photosensitizer for immune checkpoint blockade photodynamic-immunotherapy
    Wang, Ningning
    Zhou, Yaxin
    Xu, Yuwen
    Ren, Xiaomeng
    Zhou, Shiyao
    Shang, Qi
    Jiang, Yue
    Luan, Yuxia
    CHEMICAL ENGINEERING JOURNAL, 2020, 400
  • [9] Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma
    Netto, George J.
    LANCET, 2016, 387 (10031): : 1881 - 1882
  • [10] Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge
    van der Westhuizen, Andre
    Lyle, Megan
    Graves, Moira C.
    Zhu, Xiaoqiang
    Wong, Jason W. H.
    Cornall, Kerrie
    Ren, Shu
    Pugliese, Leanna
    Levy, Richard
    Majid, Adeeb
    Vilain, Ricardo E.
    Bowden, Nikola A.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (08): : 814 - 826
12345